In the first example of synthetic lethality induced by PARP inhibition, PARP1/2 inhibitor was shown to induce chromosomal instability, cell cycle arrest and apoptosis in breast cancer patients carrying heterozygous loss-of-function BRCA mutations [15, 16]. The gene discussed is PARP1; the disease is breast carcinoma.